Virtual Bioequivalence Assessment of Long-acting Injectable Suspensions Using PBPK Modeling: Part 1. Impact of particle Size on Formulation Variability. - Morris NM; Djehizian A; Mittapelly N; Telaprolu KC; Holland BW; McNally K; Polak S; Jamei M; Alam K; Tsakalozou E; Donnelly M; Feng K; et al. (The AAPS journal, 2026)